arrow
G

Gülhadiye Avcu

adana numune training & research hospital
H指数:10
被引数:336

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Carbapenem resistance and mortality in pediatric Acinetobacter bloodstream infections: determinants from a 12-year tertiary-care cohort study

碳青霉烯耐药性和死亡率在儿科鲍曼不动杆菌血流感染中的决定因素:一项为期12年的三级医疗机构队列研究

2026-10-200
PRE
Pediatric invasive meningococcal disease in Türkiye during the post-pandemic period: increased reported cases and predominance of serogroup B and severity determined by a clinical form in a multicenter hospital-based cohort

后疫情时期土耳其儿童侵袭性脑膜炎球菌病:报告病例增加、B群血清型占主导地位以及临床分型决定严重程度的基于多中心医院的队列研究

2026-09-280
PRE
Pediatric brucellosis: predictors of hospitalization, complications, and relapse in a nationwide multicenter cohort

儿童布鲁氏菌病:全国多中心队列中住院、并发症及复发的预测因素

2026-08-150
PRE
Clinical characteristics and predictors of severe pertussis in hospitalized children after the COVID-19 period in Türkiye: a multicenter study

土耳其后COVID-19时期住院儿童重症百日咳的临床特征和预测因素:一项多中心研究

2026-07-150
PRE
Burden, Risk Factors, and Clinical Outcomes of Pediatric Influenza in a Population with Extremely Low Vaccine Coverage

极低疫苗接种覆盖率人群中儿科流感负担、风险因素及临床结局

2026-05-010
PRE
Influenza vaccination rates in children: a multicenter nationwide study

儿童流感疫苗接种率:一项多中心全国性研究

2026-05-010
PRE
Analysis of the risk factors associated with bloodstream infections caused by Candida parapsilosis in pediatric patients and the determinants of fluconazole non-susceptibility: a retrospective 15-year cohort study

儿科患者近平滑假丝酵母菌引起血流感染的危险因素分析及氟康唑非敏感性决定因素: 一项15年回顾性队列研究

2026-01-080
OAAI
Mycoplasma pneumoniae in hospitalised children in the post-COVID era: clinical outcomes from a Turkish multicenter cohort

后COVID时代住院儿童中的肺炎支原体:来自土耳其多中心队列的临床结局

2025-11-200
PRE
A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey
2023-05-042
OAAI
Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines

医护人员推荐疫苗的接种状况及对SARS-CoV-2疫苗的接受程度评价

2022-06-174
OAAI